Text version
Hi! Jim Phelps here with our next volume of Quick Takes.
First, let’s look at a review on the utility of genetic testing in the prescribing of antidepressants. Does the use of the genetic tests improve outcomes? You’d think that the answer to this is clearly yes if you would just look at what younger people in our profession are doing. They seem to be adopting these tests very aggressively. I confess that, being older, I wonder if maybe I’m just stuck in the old ways. In that context, it’s useful to have this review from a 2018 volume of the American Journal of Psychiatry . Indeed, someday there will almost surely be a day when our diagnostic process is not based on DSM symptom criteria but on the use of some kind of biomarkers, and we’ll use those markers to guide treatment. And we don’t want to be late
Unlock this Quick Take and earn 0.50 CMEs
Become a Silver, Gold, Silver extended or Gold extended Member.
Already have an account? Sign in
